Title of Collaborative Activity:
Interagency Midazolam Product Coordination Team
Description of Collaborative Activity:
HHS-led effort to facilitate activities, both research and regulatory, related to the FDA approval midazolam for use in treating nerve agent exposure.
Type of Collaborative Activity:
Advisory Group
Year the Collaborative Activity Originated:
2011
NIH Participating Institutes/Centers/Office of the Director:
NIAID, NINDS
HHS Agency Collaborators on this Activity:
FDA, OS
